HOME | PRODUCTS | OSTEOPOROSIS | Otosclerosis| BIOTINIDASE DEFICIENCY | RESEARCH | CONTACT US | PRIVACY POLICY

 

Table 1. Initial characteristics of patients:

Patient characteristics

      Group A       (MFP/Ca intermittent)     (n=45)

Group B (MFP/Ca continuous) (n=44)

Group C             (Ca only)       (n=45)

Mean Age (years)

64.3+6.3

65.5+6.0

63.7+6.1

Mean Weight (kg)

60.0+10

63.9+7.3

62.4+7.3

Mean height (cm)

160.4+6.2

168.6+5.7

160.6+5.5

Mean loss of height (cm) (a)

-4.7+3.1

-5.7+2.7

-4.7+2.4

Mean BMD L2-4 (T score)

-3.51

-3.38

-3.45

Mean BMD femur, neck (T score)

-2.64

-2.45

-2.61

Mean BMD femur, Ward’s triangle (T score)

-3.14

-3.08

3.07

Mean BMD femur, trochanter (T score)

-3.07

-3.03

-3.18

Mean BMD radius 1/3 (T score)

-3.58

-3.33

-3.34

Mean BMD radius 1/10 (T score)

-3.15

-2.87

-2.77

Pain at rest (yes/no)

33/12

36/8

32/13

Fractures, vertebral (n/n patients)

161/45

170/44

147/45

Fractures, non vertebral (n/n patients)

20/13

22/12

20/14

(a) Loss of height was calculated from actual height and peak height at young adulthood as remembered by patient

 

These statement on mericon-industries.com have not been evaluated by the Food and Drug Administration. The products and research on this website are not intended to diagnose, treat or cure or prevent disease.

 

Mericon Industries, Inc

All Rights Reserved 1998-2010